🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

8,395 results for “La” Clear

  1. oncolytic virus (OVV-01) injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Neoplasms

    phase 1 small molecule active

    1 trial

  2. oral palifosfamide tris

    Alaunos Therapeutics

    Advanced Cancer

    phase 1 small molecule on hold

    1 trial

  3. pCAR-19B cells

    Chongqing Precision Biotech Co., Ltd

    Acute Lymphoblastic Leukemia, in Relapse

    phase 1 mab active

    1 trial

  4. palifosfamide-tris

    Alaunos Therapeutics

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  5. palifosfamide-tris

    Alaunos Therapeutics

    Malignancy

    phase 1 small molecule active

    1 trial

  6. patisiran

    Alnylam Netherlands B.V.

    Polyneuropathies

    phase 1 small molecule completed

    1 trial

  7. patisiran (ALN-TTR02)

    Alnylam Netherlands B.V.

    Transthyretin (TTR)-Mediated Amyloidosis

    phase 1 small molecule completed

    1 trial

  8. placebo

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  9. placebo

    Innovent Biologics (Suzhou) Co.

    Healthy

    phase 1 mab completed

    1 trial

  10. placebo control

    Takeda

    Hemophilia

    phase 1 small molecule terminated

    1 trial

  11. pomalidomide

    Celgene Europe Limited

    Multiple Myeloma in Relapse

    phase 1 small molecule completed

    1 trial

  12. prophylactic 4SCAR19 cells

    The First People's Hospital of Lianyungang

    B Acute Lymphoblastic Leukemia

    phase 1 gene therapy active

    1 trial

  13. radioactive substance

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 1 other active

    1 trial

  14. randomized, double-blinded, placebo-controlled

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of COVID-19 Caused by SARS-CoV-2

    phase 1 mab active

    1 trial

  15. recombinant adenovirus containing the ornithine transcarbamylase gene

    Ultragenyx UK Limited

    Ornithine Transcarbamylase Deficiency Disease

    phase 1 gene therapy terminated

    1 trial

  16. selinexor

    Karyopharm Therapeutics Inc

    Recurrent Melanoma

    phase 1 small molecule completed

    1 trial

  17. standard dose capecitabine

    Karyopharm Therapeutics Inc

    Rectal Neoplasms

    phase 1 small molecule active

    1 trial

  18. sulfamethoxazole + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  19. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol

    phase 1 small molecule completed

    1 trial

  20. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Circadian Rhythm Sleep Disorders

    phase 1 small molecule completed

    1 trial

  21. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    1 trial

  22. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  23. telaprevir (VX-950)

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatic Insufficiency

    phase 1 small molecule completed

    1 trial

  24. telaprevir formulation A

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources